Physician Assistant · Placentia, CA
NPI
1518364512
Since 2014
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
246 Lincoln St Apt F
Placentia, CA, 92870
Phone (951) 318-7986
Medicare paid, 2024
$56K
1,355 services
Medicare patients, 2024
174
Average age 70
Drug cost, 2024
$811K
779 prescriptions
Company payments, 2025
$1,085
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charmi Patel was code 17003 (destruction skin lesion), 398 times for 38 patients. In total Charmi Patel billed 1,355 services in 31 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-11-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 398 | 38 | $4.29 | $1,707 |
| 99213 Office E&M - Established | Office | 322 | 133 | $56.24 | $18K |
| 11301 Removal or Shaving of Skin Growth | Office | 101 | 25 | $52.84 | $5,336 |
| 17000 Destruction Skin Lesion | Office | 84 | 48 | $30.56 | $2,567 |
| 17110 Destruction Skin Lesion | Office | 68 | 54 | $66.97 | $4,554 |
| 17111 Destruction Skin Lesion | Office | 65 | 39 | $83.50 | $5,427 |
| 99203 Office E&M - New | Office | 62 | 62 | $61.66 | $3,823 |
| 11102 Skin Biopsy | Office | 39 | 34 | $51.99 | $2,028 |
| 99212 Office E&M - Established | Office | 35 | 30 | $27.97 | $979 |
| 11300 Removal or Shaving of Skin Growth | Office | 29 | 12 | $40.55 | $1,176 |
| 99214 Office E&M - Established | Office | 29 | 20 | $65.41 | $1,897 |
| 11103 Skin Biopsy | Office | 28 | 13 | $35.48 | $993 |
| 11306 Removal or Shaving of Skin Growth | Office | 21 | 14 | $49.54 | $1,040 |
By year: 2022 $14K for 278 services; 2023 $11K for 206 services; 2024 $56K for 1,355 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87635 COVID Specific | 86 | 68 | $50.43 | $4,337 |
| 87804 Immunoassay | 46 | 23 | $16.28 | $749 |
| 87426 Immunoassay | 40 | 38 | $34.76 | $1,391 |
| 87880 Immunoassay | 12 | 12 | $16.23 | $195 |
Medicare prescription drug claims, 2024
In 2024, the drug Charmi Patel prescribed most often to Medicare patients was Opzelura (Ruxolitinib Phosphate), with 105 prescriptions and refills. In total Charmi Patel wrote 779 Medicare prescriptions that cost $811K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opzelura Ruxolitinib Phosphate | 105 | 105 | 33 | $235K |
| Tacrolimus Generic | 74 | 74 | 33 | $16K |
| Clindamycin Phosphate Generic | 56 | 56 | 17 | $1,766 |
| Ketoconazole Generic | 49 | 56 | 24 | $1,729 |
| Clobetasol Propionate Generic | 45 | 45 | 24 | $1,228 |
| Dupixent Pen Dupilumab | 39 | 39 | Under 11 | $131K |
| Desonide Generic | 37 | 39 | 22 | $5,392 |
| Ciclopirox Generic | 35 | 35 | 13 | $1,485 |
| Mupirocin Generic | 35 | 35 | 28 | $182 |
| Hydrocortisone Generic | 24 | 24 | 13 | $426 |
| Doxycycline Hyclate Generic | 22 | 22 | Under 11 | $1,050 |
| Calcipotriene Generic | 19 | 19 | Under 11 | $4,636 |
| Vtama Tapinarof | 17 | 17 | Under 11 | $23K |
| Metronidazole Generic | 16 | 16 | Under 11 | $793 |
| Triamcinolone Acetonide Generic | 15 | 19 | Under 11 | $163 |
Brand drugs: 234 claims; generic drugs: 545 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charmi Patel $1,085 ($1,085 in general payments such as food, travel and fees) from 14 companies. The largest payer was Arcutis Biotherapeutics, Inc. with $191.
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | 12 | $191 |
| Verrica Pharmaceuticals Inc. VRCA | 25 | $188 |
| Incyte Corporation INCY | 20 | $183 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $81.85 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $61.88 |
| Genzyme Corporation SNY | 2 | $55.5 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $50.79 |
| Lilly USA, LLC LLY | 2 | $48.66 |
| UCB, Inc. UCB.BR | 2 | $48.47 |
| Abbvie Inc. ABBV | 3 | $45.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.